Discontinued — last reported Q4 '16
An increase indicates active organizational restructuring, while a decrease suggests the completion of operational realignment phases.
This metric represents non-recurring expenses incurred due to fundamental shifts in the company's organizational structu...
Similar to 'restructuring charges' or 'transformation costs' reported by other large-cap pharmaceutical and life sciences firms.
zts_segment_certain_significant_items_charges_due_to_operating_model_changes